Rashid Sultan Elahi, MD
Nephrology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 10 carriers
- Office
- 1
Offices
1 location
Hospitals listed: 552711 · 552848 · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
36 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Elahi’s office at (408) 937-9009 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A54268 · Current
Licensed to practise in California · since 1995 · expires 2028-09-30 · University of Karachi, Dow Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$147,459
Medicare paid this office $147,459 for 149 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $56,535 | $347 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $34,006 | $291 |
| Return visit (30+ min) | 62 | $17,965 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $11,586 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $9,687 | $76 |
See all 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $56,535 | $347 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $34,006 | $291 |
| Return visit (30+ min) | 62 | $17,965 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $11,586 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $9,687 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,693 | $167 |
| Short return visit (20+ min) | 32 | $3,939 | $84 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $2,442 | $188 |
Who their Medicare patients are
149 Original Medicare patients in 2024. Average age 75 · Under 65 17% · 85 and older 24% · Women 42% · Also on Medicaid 68% · Health risk score 5.08. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75% · Coronary heart disease 50% · Heart failure 46% · Atrial fibrillation 32% · COPD 26% · Dementia 20% · Depression 19% · Stroke 13% · Cancer 12%.
The office billed $300,199, Medicare allowed $185,121 and paid $147,459; for 797 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 149 | 797 | 75 | 5.08 | $300,199 | $147,459 |
| 2023 | 171 | 993 | 75 | 4.95 | $349,169 | $163,397 |
| 2022 | 166 | 1,014 | 74 | 4.96 | $344,349 | $158,046 |
| 2021 | 126 | 879 | 73 | 4.53 | $330,138 | $154,595 |
| 2020 | 152 | 1,388 | 72 | 5.42 | $466,003 | $184,200 |
| 2019 | 233 | 1,541 | 71 | 5.51 | $506,796 | $198,005 |
| 2018 | 196 | 1,576 | 72 | 5.30 | $423,076 | $215,990 |
| 2017 | 220 | 1,806 | 71 | 4.94 | $487,988 | $220,821 |
| 2016 | 193 | 1,778 | 72 | 4.71 | $483,899 | $218,417 |
| 2015 | 231 | 2,186 | 71 | 4.88 | $528,030 | $239,135 |
| 2014 | 257 | 2,455 | 71 | 4.46 | $601,946 | $268,663 |
| 2013 | 330 | 3,228 | 71 | 4.42 | $755,240 | $330,283 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $67,808 | $331 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $22,631 | $276 |
| Return visit (30+ min) | 79 | $19,786 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $16,016 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $15,905 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,397 | $160 |
| Short return visit (20+ min) | 31 | $4,266 | $89 |
2022: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $81,999 | $333 |
| Return visit (30+ min) | 75 | $23,551 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $15,987 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $9,491 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $7,946 | $181 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $7,796 | $278 |
| New patient visit (45+ min) | 21 | $3,236 | $154 |
| Short return visit (20+ min) | 12 | $1,239 | $89 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $1,000 | $9 |
| Hemodialysis procedure with physician evaluation | 14 | $928 | $66 |
2021: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $80,515 | $335 |
| Return visit (30+ min) | 75 | $24,529 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $9,352 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $8,606 | $183 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 13 | $8,359 | $279 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $7,029 | $66 |
| New patient visit (60+ min) | 14 | $2,965 | $212 |
| New patient visit (45+ min) | 12 | $1,932 | $161 |
2020: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $79,997 | $267 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $20,813 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $20,694 | $95 |
| Return visit (30+ min) | 74 | $17,597 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $14,821 | $185 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $6,082 | $225 |
| Hemodialysis procedure with physician evaluation | 13 | $3,574 | $67 |
2019: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 36 | $79,480 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $30,429 | $95 |
| Return visit (30+ min) | 99 | $26,177 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $13,973 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $13,755 | $66 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $8,436 | $222 |
| Critical care, first 30-74 minutes | 11 | $7,193 | $194 |
| New patient visit (60+ min) | 19 | $3,689 | $194 |
| Dialysis services, per day, less than full month service (20 years or older) | 42 | $1,330 | $7 |
2018: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $80,722 | $290 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $27,021 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $26,083 | $106 |
| Return visit (30+ min) | 103 | $24,400 | $111 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $19,358 | $245 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $14,835 | $206 |
| New patient visit (45+ min) | 16 | $2,661 | $166 |
| Short return visit (20+ min) | 15 | $1,714 | $78 |
| Dialysis services, per day, less than full month service (20 years or older) | 17 | $1,354 | $8 |
2017: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 44 | $74,409 | $257 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $26,455 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $26,042 | $65 |
| Return visit (30+ min) | 97 | $23,389 | $100 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $21,783 | $216 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $18,129 | $181 |
| New patient visit (45+ min) | 20 | $3,040 | $152 |
| New patient visit (60+ min) | 11 | $2,093 | $190 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $2,075 | $122 |
| Short return visit (20+ min) | 17 | $1,770 | $63 |
| Dialysis services, per day, less than full month service (20 years or older) | 21 | $1,276 | $7 |
2016: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $72,943 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $26,299 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $25,555 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $22,603 | $217 |
| Return visit (30+ min) | 88 | $22,574 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $17,665 | $180 |
| Hemodialysis procedure with physician evaluation | 14 | $3,104 | $65 |
| New patient visit (60+ min) | 15 | $2,841 | $189 |
| Short return visit (20+ min) | 25 | $2,409 | $63 |
| New patient visit (45+ min) | 11 | $1,542 | $140 |
| Dialysis services, per day, less than full month service (20 years or older) | 14 | $1,042 | $7 |
2015: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $82,708 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $32,112 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $31,170 | $93 |
| Return visit (30+ min) | 99 | $20,414 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $20,010 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $19,536 | $181 |
| Short return visit (20+ min) | 43 | $4,755 | $68 |
| New patient visit (45+ min) | 26 | $3,939 | $151 |
| New patient visit (60+ min) | 18 | $3,417 | $190 |
| Dialysis services, per day, less than full month service (20 years or older) | 25 | $2,532 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $2,442 | $122 |
2014: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 51 | $80,276 | $256 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $42,144 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $34,843 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 110 | $24,822 | $180 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $21,472 | $217 |
| Return visit (30+ min) | 91 | $18,878 | $97 |
| Critical care, first 30-74 minutes | 22 | $11,142 | $195 |
| Short return visit (20+ min) | 72 | $8,140 | $67 |
| Hemodialysis procedure with physician evaluation | 26 | $4,646 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $4,138 | $122 |
| New patient visit (60+ min) | 20 | $3,768 | $188 |
| New patient visit (45+ min) | 24 | $3,420 | $142 |
| Long return visit (40+ min) | 20 | $2,667 | $133 |
| Dialysis services, per day, less than full month service (20 years or older) | 28 | $2,236 | $7 |
2013: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $97,838 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $54,517 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $46,904 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $30,481 | $174 |
| Return visit (30+ min) | 107 | $21,943 | $98 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $14,649 | $212 |
| Hemodialysis procedure with physician evaluation | 52 | $13,937 | $62 |
| Critical care, first 30-74 minutes | 28 | $12,350 | $190 |
| Short return visit (20+ min) | 89 | $11,476 | $65 |
| New patient visit (60+ min) | 34 | $6,333 | $186 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $4,527 | $119 |
| Long return visit (40+ min) | 25 | $3,448 | $133 |
| New patient visit (45+ min) | 23 | $3,358 | $146 |
| Dialysis services, per day, less than full month service (20 years or older) | 51 | $2,331 | $7 |
Medicaid work
$10,380 in 2024
Medicaid paid $10,380 for 246 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 168 | $8,310 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 21 | $1,073 |
| Return visit (30+ min) | 57 | $996 |
| 2024 | 246 | 3 | 24 | $10,380 |
| 2023 | 577 | 4 | 33 | $15,355 |
| 2022 | 520 | 3 | 30 | $14,809 |
| 2021 | 486 | 2 | 26 | $17,896 |
| 2020 | 329 | 2 | 24 | $21,032 |
| 2019 | 446 | 2 | 27 | $18,222 |
| 2018 | 484 | 3 | 29 | $20,421 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 314 | $12,629 |
| Return visit (30+ min) | 193 | $1,810 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 31 | $850 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 39 | $67 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 303 | $14,431 |
| Return visit (30+ min) | 147 | $231 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 70 | $146 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 295 | $17,647 |
| Return visit (30+ min) | 191 | $248 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 239 | $20,842 |
| Return visit (30+ min) | 90 | $190 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 262 | $17,829 |
| Return visit (30+ min) | 184 | $392 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 269 | $18,127 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 24 | $1,539 |
| Return visit (30+ min) | 191 | $755 |
Drugs they prescribed that Part D paid
$113,005
Pharmacies billed $113,005 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 779) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
661 generic and 118 brand-name prescriptions · $113,005 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Veltassa | 15 | $14,650 | $977 |
| Lokelma | 15 | $11,718 | $781 |
| Sevelamer Carbonate | 74 | $8,943 | $121 |
| Prosol | 50 | $8,356 | $167 |
| Calcium Acetate | 32 | $1,673 | $52 |
See all 18 drugs
| Veltassa | 15 | $14,650 | $977 |
| Lokelma | 15 | $11,718 | $781 |
| Sevelamer Carbonate | 74 | $8,943 | $121 |
| Prosol | 50 | $8,356 | $167 |
| Calcium Acetate | 32 | $1,673 | $52 |
| Calcitriol | 114 | $1,317 | $12 |
| Hydralazine | 44 | $892 | $20 |
| Losartan | 74 | $555 | $7 |
| Amlodipine Besylate | 99 | $473 | $5 |
| Metoprolol | 25 | $361 | $14 |
| Allopurinol | 29 | $312 | $11 |
| Furosemide | 34 | $153 | $5 |
| Lisinopril | 26 | $148 | $6 |
| Clonidine | 19 | $114 | $6 |
| Minoxidil | 11 | $85 | $8 |
| Spironolactone | 14 | $72 | $5 |
| Hydrochlorothiazide | 17 | $40 | $2 |
| Metoprolol | 14 | $11 | $1 |
Year by year
| 2024 | 779 | 114 | 0% (0) | 15% | $113,005 |
| 2023 | 739 | 124 | 0% (0) | 16% | $160,409 |
| 2022 | 766 | 117 | 0% (0) | 10% | $129,825 |
| 2021 | 756 | 115 | 0% (0) | 14% | $121,929 |
| 2020 | 801 | 101 | 0% (0) | 20% | $156,315 |
| 2019 | 802 | 97 | 0% (0) | 20% | $166,760 |
| 2018 | 790 | 92 | 0% (0) | 21% | $158,221 |
| 2017 | 1,027 | 94 | 0% (0) | 38% | $333,552 |
| 2016 | 1,133 | 103 | 0% (0) | 43% | $321,586 |
| 2015 | 1,334 | 105 | 0% (0) | None | $350,826 |
| 2014 | 1,226 | 109 | 0% (0) | 45% | $264,797 |
| 2013 | 1,151 | 112 | 0% (0) | None | $208,037 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Renvela | 16 | $42,688 | $2,668 |
| Sevelamer Carbonate | 61 | $19,335 | $317 |
| Cinacalcet | 14 | $17,853 | $1,275 |
| Veltassa | 11 | $10,949 | $995 |
| Prosol | 38 | $6,956 | $183 |
| Calcium Acetate | 40 | $5,437 | $136 |
| Calcitriol | 126 | $1,811 | $14 |
| Midodrine | 15 | $1,768 | $118 |
| Metoprolol | 37 | $995 | $27 |
| Hydralazine | 33 | $975 | $30 |
| Losartan | 73 | $798 | $11 |
| Amlodipine Besylate | 55 | $582 | $11 |
| Allopurinol | 15 | $306 | $20 |
| Furosemide | 44 | $256 | $6 |
| Lisinopril | 18 | $246 | $14 |
| Hydrochlorothiazide | 26 | $186 | $7 |
2022: 17 drugs
| Renvela | 12 | $42,990 | $3,582 |
| Sevelamer Carbonate | 70 | $18,097 | $259 |
| Cinacalcet | 15 | $13,433 | $896 |
| Clinisol | 50 | $10,427 | $209 |
| Calcium Acetate | 57 | $5,539 | $97 |
| Procrit | 12 | $3,230 | $269 |
| Calcitriol | 114 | $1,605 | $14 |
| Losartan | 99 | $1,129 | $11 |
| Hydralazine | 37 | $759 | $21 |
| Metoprolol | 21 | $505 | $24 |
| Amlodipine Besylate | 62 | $501 | $8 |
| Allopurinol | 23 | $445 | $19 |
| Furosemide | 34 | $242 | $7 |
| Potassium Chloride | 14 | $166 | $12 |
| Carvedilol | 20 | $153 | $8 |
| Metoprolol | 13 | $111 | $9 |
| Hydrochlorothiazide | 21 | $91 | $4 |
2021: 20 drugs
| Renvela | 17 | $53,983 | $3,175 |
| Sevelamer Carbonate | 44 | $24,776 | $563 |
| Clinisol | 61 | $11,889 | $195 |
| Prosol | 34 | $6,114 | $180 |
| Calcium Acetate | 38 | $2,835 | $75 |
| Calcitriol | 109 | $2,041 | $19 |
| Midodrine | 16 | $926 | $58 |
| Losartan | 65 | $792 | $12 |
| Metoprolol | 29 | $667 | $23 |
| Hydralazine | 40 | $630 | $16 |
| Allopurinol | 39 | $468 | $12 |
| Amlodipine Besylate | 70 | $408 | $6 |
| Ramipril | 15 | $313 | $21 |
| Furosemide | 22 | $255 | $12 |
| Lisinopril | 22 | $196 | $9 |
| Carvedilol | 17 | $191 | $11 |
| Potassium Chloride | 15 | $178 | $12 |
| Clonidine | 14 | $101 | $7 |
| Hydrochlorothiazide | 22 | $83 | $4 |
| Metoprolol | 16 | $68 | $4 |
2020: 19 drugs
| Renvela | 24 | $64,533 | $2,689 |
| Sevelamer Carbonate | 52 | $28,599 | $550 |
| Clinisol | 53 | $9,873 | $186 |
| Procrit | 15 | $6,519 | $435 |
| Prosol | 26 | $5,575 | $214 |
| Calcium Acetate | 58 | $4,699 | $81 |
| Calcitriol | 131 | $2,625 | $20 |
| Midodrine | 23 | $959 | $42 |
| Losartan | 61 | $749 | $12 |
| Potassium Chloride | 31 | $701 | $23 |
| Metoprolol | 29 | $625 | $22 |
| Hydralazine | 26 | $542 | $21 |
| Amlodipine Besylate | 58 | $355 | $6 |
| Allopurinol | 35 | $320 | $9 |
| Furosemide | 31 | $251 | $8 |
| Clonidine | 17 | $225 | $13 |
| Lisinopril | 19 | $180 | $9 |
| Carvedilol | 15 | $148 | $10 |
| Metoprolol | 37 | $99 | $3 |
2019: 16 drugs
| Renvela | 44 | $68,202 | $1,550 |
| Sevelamer Carbonate | 58 | $35,596 | $614 |
| Clinisol | 50 | $9,295 | $186 |
| Prosol | 57 | $7,941 | $139 |
| Calcium Acetate | 80 | $6,166 | $77 |
| Calcitriol | 126 | $2,298 | $18 |
| Metoprolol | 22 | $715 | $32 |
| Hydralazine | 20 | $624 | $31 |
| Losartan | 58 | $501 | $9 |
| Allopurinol | 40 | $424 | $11 |
| Amlodipine Besylate | 58 | $406 | $7 |
| Lisinopril | 35 | $280 | $8 |
| Furosemide | 35 | $246 | $7 |
| Clonidine | 13 | $177 | $14 |
| Carvedilol | 11 | $116 | $11 |
| Metoprolol | 34 | $112 | $3 |
2018: 17 drugs
| Renvela | 54 | $82,554 | $1,529 |
| Sevelamer Carbonate | 48 | $24,371 | $508 |
| Sensipar | 12 | $20,001 | $1,667 |
| Clinisol | 33 | $6,216 | $188 |
| Calcium Acetate | 98 | $5,601 | $57 |
| Prosol | 49 | $5,548 | $113 |
| Calcitriol | 90 | $2,599 | $29 |
| Plenamine | 18 | $1,417 | $79 |
| Metoprolol | 16 | $649 | $41 |
| Hydralazine | 31 | $559 | $18 |
| Losartan | 55 | $389 | $7 |
| Allopurinol | 37 | $388 | $10 |
| Amlodipine Besylate | 46 | $299 | $7 |
| Lisinopril | 61 | $283 | $5 |
| Metoprolol | 43 | $227 | $5 |
| Clonidine | 12 | $163 | $14 |
| Furosemide | 21 | $144 | $7 |
2017: 20 drugs
| Renvela | 111 | $151,094 | $1,361 |
| Sensipar | 67 | $104,968 | $1,567 |
| Procrit | 22 | $19,526 | $888 |
| Intralipid | 52 | $17,973 | $346 |
| Prosol | 71 | $16,524 | $233 |
| Calcium Acetate | 73 | $4,846 | $66 |
| Clinisol | 45 | $4,233 | $94 |
| Calcitriol | 109 | $1,932 | $18 |
| Dextrose in Water | 24 | $1,086 | $45 |
| Metoprolol | 28 | $667 | $24 |
| Hydralazine | 40 | $657 | $16 |
| Valsartan | 14 | $516 | $37 |
| Amlodipine Besylate | 82 | $366 | $4 |
| Allopurinol | 33 | $344 | $10 |
| Lisinopril | 73 | $333 | $5 |
| Clonidine | 30 | $177 | $6 |
| Losartan | 21 | $159 | $8 |
| Metoprolol | 34 | $132 | $4 |
| Furosemide | 12 | $59 | $5 |
| Gabapentin | 11 | $55 | $5 |
2016: 17 drugs
| Renvela | 122 | $155,106 | $1,271 |
| Sensipar | 68 | $92,794 | $1,365 |
| Prosol | 121 | $35,892 | $297 |
| Dextrose in Water | 81 | $7,760 | $96 |
| Calcium Acetate | 64 | $6,737 | $105 |
| Calcitriol | 117 | $2,093 | $18 |
| Hydralazine | 57 | $930 | $16 |
| Metoprolol | 48 | $756 | $16 |
| Amlodipine Besylate | 102 | $610 | $6 |
| Allopurinol | 36 | $473 | $13 |
| Valsartan | 17 | $358 | $21 |
| Potassium Chloride | 26 | $294 | $11 |
| Lisinopril | 74 | $276 | $4 |
| Clonidine | 36 | $198 | $5 |
| Losartan | 21 | $123 | $6 |
| Furosemide | 24 | $120 | $5 |
| Metoprolol | 27 | $96 | $4 |
2015: 25 drugs
| Renvela | 136 | $168,040 | $1,236 |
| Sensipar | 85 | $92,108 | $1,084 |
| Prosol | 104 | $31,132 | $299 |
| Velphoro | 16 | $20,127 | $1,258 |
| Intralipid | 25 | $4,931 | $197 |
| Calcium Acetate | 34 | $4,248 | $125 |
| Clinisol | 44 | $3,623 | $82 |
| Cyclosporine Modified | 12 | $3,160 | $263 |
| Clonidine | 17 | $2,760 | $162 |
| Dextrose in Water | 52 | $2,301 | $44 |
| Calcitriol | 97 | $2,240 | $23 |
| Metoprolol | 43 | $894 | $21 |
| Valsartan | 22 | $804 | $37 |
| Amlodipine Besylate | 148 | $685 | $5 |
| Hydralazine | 62 | $639 | $10 |
| Lisinopril | 91 | $482 | $5 |
| Allopurinol | 40 | $475 | $12 |
| Losartan | 38 | $307 | $8 |
| Furosemide | 57 | $239 | $4 |
| Metoprolol | 51 | $236 | $5 |
| Clonidine | 32 | $197 | $6 |
| Potassium Chloride | 16 | $194 | $12 |
| Minoxidil | 13 | $77 | $6 |
| Gabapentin | 17 | $72 | $4 |
| Losartan-Hydrochlorothiazide | 12 | $62 | $5 |
2014: 23 drugs
| Renvela | 119 | $118,459 | $995 |
| Sensipar | 66 | $50,448 | $764 |
| Prosol | 127 | $31,756 | $250 |
| Clinisol | 53 | $6,298 | $119 |
| Calcium Acetate | 51 | $6,243 | $122 |
| Diovan | 23 | $4,089 | $178 |
| Intralipid | 13 | $3,349 | $258 |
| Cyclosporine Modified | 12 | $2,917 | $243 |
| Clonidine | 12 | $2,625 | $219 |
| Calcitriol | 105 | $2,541 | $24 |
| Dextrose in Water | 51 | $2,168 | $43 |
| Hydralazine | 51 | $863 | $17 |
| Metoprolol | 32 | $743 | $23 |
| Amlodipine Besylate | 129 | $729 | $6 |
| Labetalol | 14 | $450 | $32 |
| Lisinopril | 82 | $432 | $5 |
| Mycophenolate Mofetil | 12 | $426 | $35 |
| Losartan | 18 | $315 | $18 |
| Furosemide | 46 | $219 | $5 |
| Clonidine | 25 | $181 | $7 |
| Metoprolol | 38 | $179 | $5 |
| Allopurinol | 19 | $118 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $111 | $10 |
2013: 29 drugs
| Renvela | 122 | $110,045 | $902 |
| Sensipar | 49 | $32,970 | $673 |
| Aranesp | 15 | $12,885 | $859 |
| Prosol | 29 | $10,246 | $353 |
| Calcium Acetate | 63 | $7,316 | $116 |
| Clonidine | 30 | $5,518 | $184 |
| Diovan | 19 | $3,000 | $158 |
| Cyclosporine Modified | 12 | $2,920 | $243 |
| Calcitriol | 94 | $2,232 | $24 |
| Azor | 12 | $1,986 | $165 |
| Metoprolol | 58 | $1,513 | $26 |
| Dextrose in Water | 29 | $1,163 | $40 |
| Lisinopril | 130 | $913 | $7 |
| Amlodipine Besylate | 106 | $849 | $8 |
| Minoxidil | 27 | $573 | $21 |
| Labetalol | 12 | $536 | $45 |
| Losartan | 38 | $478 | $13 |
| Mycophenolate Mofetil | 13 | $464 | $36 |
| Nifedipine Er | 11 | $430 | $39 |
| Hydralazine | 25 | $397 | $16 |
| Lidocaine-Prilocaine | 14 | $354 | $25 |
| Furosemide | 50 | $243 | $5 |
| Clonidine | 21 | $176 | $8 |
| Pravastatin | 12 | $161 | $13 |
| Hydrochlorothiazide | 21 | $157 | $7 |
| Isosorbide Mononitrate Er | 11 | $154 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $144 | $12 |
| Metoprolol | 29 | $125 | $4 |
| Allopurinol | 14 | $57 | $4 |
Money from drug and device companies
$697 in 2025
| 2025 | 11 | 17 | None | $697 |
| 2024 | 6 | 8 | None | $288 |
| 2023 | 6 | 11 | None | $288 |
| 2022 | 4 | 5 | None | $110 |
| 2021 | 1 | 1 | None | $32 |
| 2020 | 3 | 3 | None | $66 |
| 2019 | 7 | 15 | None | $451 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Akebia Therapeutics | Vafseo | $151 | 2 payments
|
| Otsuka America Pharmaceutical | Voyxact | $151 | 2 payments
|
| Travere Therapeutics | Filspari | $132 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $74 | 3 payments
|
| Ardelyx | Ibsrela | $40 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $31 | 1 payment
|
See all 17 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-09 | Voyxact | $125 |
| Travere Therapeutics | Meals · 2025-11-12 | Filspari | $130 |
| Xeris Pharmaceuticals | Meals · 2025-10-29 | Keveyis | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-24 | Kerendia | $27 |
| Ardelyx | Meals · 2025-09-03 | Ibsrela | $19 |
| Apellis Pharmaceuticals | Meals · 2025-08-27 | Empaveli | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-08-13 | Jynarque | $26 |
| Travere Therapeutics | Education · 2025-08-06 | Filspari | $2 |
| Aurinia Pharma U.S. | Meals · 2025-07-30 | Lupkynis | $25 |
| Akebia Therapeutics | Meals · 2025-06-18 | Vafseo | $125 |
| ANI Pharmaceuticals | Meals · 2025-06-18 | Purified Cortrophin Gel | $31 |
| Novartis Pharmaceuticals | Meals · 2025-06-04 | Fabhalta | $25 |
| Akebia Therapeutics | Meals · 2025-05-28 | Vafseo | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-14 | Kerendia | $23 |
| Ardelyx | Meals · 2025-04-30 | Ibsrela | $21 |
| Calliditas Therapeutics US | Meals · 2025-02-12 | Tarpeyo | $31 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-29 | Kerendia | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $288
| Bayer Healthcare Pharmaceuticals | Kerendia | $98 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $54 | 2 payments
|
| Ardelyx | Ibsrela | $50 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $30 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $29 | 1 payment
|
| Novartis Pharmaceuticals | Fabhalta | $27 | 1 payment
|
2023: $288
| AstraZeneca Pharmaceuticals LP | Lokelma | $91 | 4 payments
|
| Vifor Pharma | Korsuva | $56 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $53 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $33 | 1 payment
|
| Ardelyx | Ibsrela | $27 | 1 payment
|
| Travere Therapeutics | None | $27 | 1 payment
|
2022: $110
| Vifor Pharma | Veltassa | $48 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $23 | 1 payment
|
| Amgen | Parsabiv | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $18 | 1 payment
|
2021: $32
| Amgen | Parsabiv | $32 | 1 payment
|
2020: $66
| Fresenius USA Marketing | Velphoro | $24 | 1 payment
|
| Amgen | Parsabiv | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $18 | 1 payment
|
2019: $451
| Relypsa | Veltassa | $125 | 1 payment
|
| Amgen | Aranesp | $102 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $79 | 4 payments
|
| Fresenius USA Marketing | Velphoro | $69 | 3 payments
|
| Medtronic Vascular | Endurant | $26 | 1 payment
|
| GlaxoSmithKline | Benlysta | $25 | 1 payment
|
| Alexion Pharmaceuticals | Soliris | $25 | 1 payment
|
Checkups this office reported
7 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 221 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 92%That's most of the people this applied to. | 39 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 16%That's few of the people this applied to. Better on this measure. | 111 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 857 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 92%That's most of the people this applied to. | 167 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 103 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 304 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- ONC-ACB Surveillance Attestation
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1790753408
- Licence
- AZ 25375, CA A54268California A54268: Current · expires 2028-09-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 200 Jose Figueres Ave, Suite 270, San Jose, CA, 95116
- NPI first listed
- 2006-03-09
- NPI last updated
- 2009-05-18
This is when the NPI record was last certified, not a medical board exam.